Chronic chyluria: a clinical study of 3 patients.
Studies of patients with chyluria or chylothorax have demonstrated significant disruptions of protein, blood and fat metabolism that may result in iron deficiency anemia, hypoproteinemia, hypolipidemia and malnutrition. To document the sequential development of these complications we performed serial clinical and biochemical studies for 2 to 12 years in 3 patients with presumed filarial chyluria whose sole treatment had been diethylcarbamazine. Despite the chronic loss of chyle in the urine these 3 patients did not have significant complications during the period of observation. The weight and blood pressure remained stable. No persistent anemia, hypoproteinemia or hypolipidemia was noted. Except for 1 patient in whom a transient decrease of the creatinine clearance developed during pregnancy, no permanent renal function impairment occurred. These observations suggest that chronic chyluria may not always result in serious alterations of the physical status or body functions of these patients requiring surgical repair, and supports the hypothesis that untreated chyluria could be a relatively benign process in our milieu.
D000328:Adult; D001794:Blood Pressure; D001827:Body Height; D001835:Body Weight; D002908:Chronic Disease; D002913:Chyle; D004049:Diethylcarbamazine / Q000627:therapeutic use; D005260:Female; D005368:Filariasis / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors; D014556:Urine; D014958:Wuchereria bancrofti
D006454:Hemoglobins; D004049:Diethylcarbamazine